DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)
South Korea · Delayed Price · Currency is KRW 3,500.00
-5.00 (-0.14%)
At close: Sep 11, 2026
DongKoo Bio & Pharma Market Cap
DongKoo Bio & Pharma has a market cap or net worth of 94.65 billion as of September 11, 2026. Its market cap has decreased by -31.37% in one year.
Market Cap
94.65B
Enterprise Value
166.73B
Revenue
241.43B
Ranking
n/a
PE Ratio
2.94
Stock Price
3,500.00
ChartMarket Cap Chart
Since February 19, 2018, DongKoo Bio & Pharma's market cap has decreased from 369.75B to 94.65B, a decrease of -74.40%. That is a compound annual growth rate of -14.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 94.65B | -36.01% |
| Dec 30, 2025 | 147.92B | 12.87% |
| Dec 30, 2024 | 131.05B | -16.18% |
| Dec 28, 2023 | 156.35B | -7.82% |
| Dec 29, 2022 | 169.61B | -27.07% |
| Dec 30, 2021 | 232.56B | -3.34% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HYUNDAI BIOLAND | 117.75B |
| Ahn-Gook Pharmaceutical | 115.36B |
| High Tech Pharm | 109.52B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 104.28B |
| OPTUS Pharmaceutical | 101.11B |
| H.PIO | 84.88B |
| Sam-A Pharm. | 84.84B |
| KOREA PHARMA | 83.65B |